As of 2026-04-05, the Intrinsic Value of Diagnos Laboratorium Utama PT Tbk (DGNS.JK) is 22.26 IDR. This DGNS.JK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 302.00 IDR, the upside of Diagnos Laboratorium Utama PT Tbk is -92.60%.
The range of the Intrinsic Value is 9.26 - 41.91 IDR
Based on its market price of 302.00 IDR and our intrinsic valuation, Diagnos Laboratorium Utama PT Tbk (DGNS.JK) is overvalued by 92.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9.26 - 41.91 | 22.26 | -92.6% |
| DCF (Growth 10y) | 52.84 - 103.34 | 73.09 | -75.8% |
| DCF (EBITDA 5y) | 268.12 - 726.37 | 431.60 | 42.9% |
| DCF (EBITDA 10y) | 253.49 - 701.37 | 410.26 | 35.8% |
| Fair Value | -38.06 - -38.06 | -38.06 | -112.60% |
| P/E | (23.38) - 138.83 | 46.39 | -84.6% |
| EV/EBITDA | 55.91 - 277.24 | 152.39 | -49.5% |
| EPV | (161.99) - (177.89) | (169.94) | -156.3% |
| DDM - Stable | (9.65) - (22.06) | (15.86) | -105.3% |
| DDM - Multi | 96.72 - 173.19 | 124.26 | -58.9% |
| Market Cap (mil) | 377,500.00 |
| Beta | 0.57 |
| Outstanding shares (mil) | 1,250.00 |
| Enterprise Value (mil) | 460,446.30 |
| Market risk premium | 7.88% |
| Cost of Equity | 12.62% |
| Cost of Debt | 26.62% |
| WACC | 14.12% |